Cinemark (NYSE:CNK – Get Free Report) had its price target boosted by equities researchers at JPMorgan Chase & Co. from $35.00 to $40.00 in a note issued to investors on Friday,Benzinga reports. The brokerage currently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s target price would indicate a potential upside of 10.71% from the company’s previous close.
Several other equities analysts have also weighed in on CNK. Zacks Research lowered shares of Cinemark from a “strong-buy” rating to a “hold” rating in a report on Tuesday, June 2nd. The Goldman Sachs Group upgraded shares of Cinemark from a “sell” rating to a “neutral” rating and upped their target price for the company from $23.00 to $30.00 in a research report on Wednesday, July 8th. Morgan Stanley set a $40.00 price target on Cinemark in a research note on Wednesday. Wells Fargo & Company raised their price target on Cinemark from $31.00 to $34.00 and gave the stock an “equal weight” rating in a research report on Friday. Finally, B. Riley Financial lifted their price objective on Cinemark from $35.00 to $37.00 and gave the stock a “neutral” rating in a research note on Friday. Nine investment analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. Based on data from MarketBeat, Cinemark presently has a consensus rating of “Moderate Buy” and an average target price of $38.00.
Read Our Latest Stock Analysis on CNK
Cinemark Trading Down 0.1%
Cinemark (NYSE:CNK – Get Free Report) last released its earnings results on Thursday, July 30th. The company reported $1.19 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.03 by $0.16. Cinemark had a net margin of 5.31% and a return on equity of 41.31%. The company had revenue of $1.09 billion for the quarter, compared to the consensus estimate of $1.03 billion. During the same period in the prior year, the company posted $0.63 EPS. The company’s revenue was up 15.5% compared to the same quarter last year. As a group, research analysts expect that Cinemark will post 2.16 EPS for the current fiscal year.
Institutional Investors Weigh In On Cinemark
Several hedge funds have recently bought and sold shares of CNK. State of New Jersey Common Pension Fund D bought a new stake in shares of Cinemark in the 4th quarter valued at $1,661,000. UBS Group AG lifted its holdings in Cinemark by 49.8% during the fourth quarter. UBS Group AG now owns 1,100,402 shares of the company’s stock worth $25,573,000 after acquiring an additional 365,630 shares in the last quarter. GHP Investment Advisors Inc. lifted its holdings in Cinemark by 80.1% during the first quarter. GHP Investment Advisors Inc. now owns 41,764 shares of the company’s stock worth $1,191,000 after acquiring an additional 18,579 shares in the last quarter. Saber Capital Managment LLC acquired a new position in Cinemark in the fourth quarter valued at about $6,300,000. Finally, MYDA Advisors LLC grew its stake in Cinemark by 215.0% in the fourth quarter. MYDA Advisors LLC now owns 315,000 shares of the company’s stock valued at $7,321,000 after acquiring an additional 215,000 shares during the period.
Cinemark News Roundup
Here are the key news stories impacting Cinemark this week:
- Positive Sentiment: Record quarterly performance: Cinemark generated $1.09 billion in revenue, its first quarter above $1 billion, up 15.5% year over year. More than 60 million moviegoers attended its theaters, supported by a broad box-office recovery. Cinemark Celebrates Record-Breaking Q2 2026 Results
- Positive Sentiment: Earnings beat expectations: Adjusted earnings were $1.19 per share, compared with the $1.03 analyst consensus and $0.63 in the prior-year quarter. Revenue also exceeded the approximately $1.03 billion estimate, providing a favorable earnings surprise. Cinemark Holdings Tops Q2 Earnings and Revenue Estimates
- Positive Sentiment: Market-share gains: Reports highlighted that Cinemark added market share during a strong box-office year, suggesting the company is benefiting not only from industry recovery but also from competitive operating gains. Cinemark Rallies After Adding Market Share
- Neutral Sentiment: The results reinforce the importance of Hollywood’s release pipeline: continued attendance and revenue growth will depend on a sustained recovery in movie releases and consumer demand.
- Negative Sentiment: Investors may be taking profits after the rally and assessing risk. Cinemark trades near its 52-week high at roughly 32 times earnings, while its debt-to-equity ratio is about 5.0, leaving the shares sensitive to any slowdown in box-office momentum or pressure on cash flow.
About Cinemark
Cinemark Holdings, Inc (NYSE: CNK) is a leading theatrical exhibitor that acquires, develops and operates motion picture theatres under the Cinemark® brand in the United States and Latin America. The company’s core business involves the presentation of first-run feature films coupled with an array of in‐theatre services, including concessions, premium auditoriums and loyalty programs. Cinemark’s exhibition portfolio encompasses both corporate‐owned and franchised complexes, offering moviegoers a range of experiences from standard screens to large‐format halls.
The company’s product offerings extend beyond ticket sales to include an assortment of concession items, such as popcorn, fountain beverages, candy and specialty snacks, as well as bar and lounge concepts in select locations.
Featured Articles
- Five stocks we like better than Cinemark
- Chevron’s Strong Quarter Shows Why It Still Leads the Energy Sector
- Amazon’s Earnings Beat Shows Why AWS Is Back at the Center of the Bull Case
- Apple’s Record Quarter Could Not Outrun Its Guidance Problem
- McKesson’s Compounding Keeps Adding Up
Receive News & Ratings for Cinemark Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cinemark and related companies with MarketBeat.com's FREE daily email newsletter.
